| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/21/2005 | US20050085627 Nucleotide sequences coding histone methyltransferase for use in identifying modulators for treatment and prevention of asthma disorders |
| 04/21/2005 | US20050085553 Remedies for mild recognition deflict |
| 04/21/2005 | US20050085548 Administering mixture of arginine and reductase inhibitase; therapy for endothelial cell diseases; hypotensive agents; cardiovascular disorders brain disorders |
| 04/21/2005 | US20050085498 a lipid soluble thiamine such as benfotiamine, creatine ethyl ester for example; reducing serum glucose levels and maintaining those reduced glucose levels over time to treat diabetic polyneuropathy, improving circulation |
| 04/21/2005 | US20050085493 Quinazolinone derivatives and their use as cb agonists |
| 04/21/2005 | US20050085450 Oral antidepressant formulation |
| 04/21/2005 | US20050085440 Formulation |
| 04/21/2005 | US20050085431 Treatment of hypertension |
| 04/21/2005 | US20050085430 Phosphodiesterase-4 (PDE4) inhibitor such as roflumilast or cilomilast; low amounts of active agents, less prone to detrimental side effects |
| 04/21/2005 | US20050085428 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease |
| 04/21/2005 | US20050085421 Derived from ghrelin polypeptide, labelled with fluorochrome and cysteine; drug screening; high throughput assay |
| 04/21/2005 | US20050085415 Nanoparticles injected directly into eye; integrin receptor antagonist; angiogenesis inhibitor, polypeptide |
| 04/21/2005 | US20050085414 Novel medical use for tachykinin antagonists |
| 04/21/2005 | US20050084936 Human regulatory proteins |
| 04/21/2005 | US20050084918 Method for the identification of agents that inhibit or promote cataracts and uses thereof |
| 04/21/2005 | US20050084897 DNA encoding human vanilloid receptor VR3 |
| 04/21/2005 | US20050084861 Methods of detecting modification of genetic material and monitoring processes thereof |
| 04/21/2005 | US20050084528 Anticoagulants comprising a synergistic mixture of nimesulide and a subtherapeutical dose of aspirin; broad spectrum of activity (i.e. activity against a wider range of agonists) with fewer side effects; typical dosage:10 mg. aspirin/12.5 mg nimesulide; admininstered orally concurrently or sequentially |
| 04/21/2005 | US20050084524 Method for potentiating activity of a chemotherapeutic drug |
| 04/21/2005 | US20050084502 Equine herpesvirus vaccine |
| 04/21/2005 | US20050084501 Therapeutic agent for a cancer and method of screening the same, and health-care auxillary food |
| 04/21/2005 | US20050084490 Boroproline compound combination therapy |
| 04/21/2005 | US20050084489 Synergistic administration of Vitaxin, a FAB fragment, or a competitive binding antibody for binding integrin alpha V beta 3 with the enzyme inhibitor; antiinflammatory, anticarcinogenic agents; autoimmune and metabolic bone disorders |
| 04/21/2005 | US20050084479 Especially lactic acid bacteria as drug delivery devices in combination with edible carriers; tissue targeted therapy |
| 04/21/2005 | CA2544630A1 Method and material for enhanced tissue-biomaterial integration |
| 04/21/2005 | CA2542099A1 Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity |
| 04/21/2005 | CA2541815A1 Methods and means for modulating lipid metabolism |
| 04/21/2005 | CA2541382A1 A solid dosage form comprising a fibrate and a statin |
| 04/21/2005 | CA2541317A1 Multi-layered polymerizing hydrogels for tissue regeneration |
| 04/21/2005 | CA2540978A1 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups |
| 04/21/2005 | CA2540147A1 Colon cleansing composition and method |
| 04/21/2005 | CA2539868A1 A method of healing skin wounds in mammals and a composition therefor |
| 04/21/2005 | CA2539568A1 Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects |
| 04/21/2005 | CA2539449A1 Pharmaceutical formulations of xanthogenates and inhibitors of viral nucleic acid replication (e.g. aciclovir) |
| 04/21/2005 | CA2538445A1 Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions |
| 04/21/2005 | CA2538104A1 Use of xenon with hypothermia for treating neonatal asphyxia |
| 04/21/2005 | CA2537315A1 Protein biomaterials and biocoacervates and methods of making and using thereof |
| 04/20/2005 | EP1523982A2 Plenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 04/20/2005 | EP1523980A2 Use of glucose uptake enhancer for reducing post-ischemic injury of the heart |
| 04/20/2005 | EP1523975A2 Pressurised metered dose inhalers (MDI) |
| 04/20/2005 | EP1523577A2 Method for diagnosis of intestinal-type gastric tumors |
| 04/20/2005 | EP1523571A2 Sgk and nedd used as diagnostic and therapeutic targets |
| 04/20/2005 | EP1523556A1 Methods of treating conditions associated with an edg-1 receptor |
| 04/20/2005 | EP1523489A2 Modified 2' and 3' -nucleoside produgs for treating flaviridae infections |
| 04/20/2005 | EP1523486A2 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity |
| 04/20/2005 | EP1523471A1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 04/20/2005 | EP1523336A1 Targeted agents for nerve regeneration |
| 04/20/2005 | EP1523330A2 Vaccine against salmonid rickettsial septicaemia based on arthrobacter cells |
| 04/20/2005 | EP1523328A2 Methods and compositions for inhibiting hiv replication |
| 04/20/2005 | EP1523325A2 Methods and compositions for treating polycystic ovary syndrome |
| 04/20/2005 | EP1523323A2 Reagents and methods for smooth muscle therapies |
| 04/20/2005 | EP1523318A2 Treatment of human multiple myeloma by curcumin |
| 04/20/2005 | EP1523316A2 Combination comprising an hmg-coa reductase inhibitor and an insulin secretor enhancer or an insulin sensitizer |
| 04/20/2005 | EP1523312A1 Use of a rhein in a therapeutic treatment requiring a rise in the rate of heme oxygenase |
| 04/20/2005 | EP1523310A2 Method to inhibit ischemia and reperfusion injury |
| 04/20/2005 | EP1523307A1 Use of neurotoxic substances for the production of a means for the treatment of joint pain and method for application of said means |
| 04/20/2005 | EP1523239A1 Use of a composition and a cleaning tablet containing said composition for disinfecting purposes |
| 04/20/2005 | EP1365737B1 Stable salts of o-acetylsalicyclic with basic amino acids |
| 04/20/2005 | EP1307263B1 New use of lipase inhibitors |
| 04/20/2005 | EP1292712A4 Means and methods for monitoring antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids |
| 04/20/2005 | EP1252158B1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 04/20/2005 | EP1189926B1 Rapid dehydration of proteins |
| 04/20/2005 | EP1185649B1 The myostatin gene promoter and inhibition of activation thereof |
| 04/20/2005 | EP1079853B1 Tuber or root derived protease inhibitors for preventing or treating inflammation or pruritis |
| 04/20/2005 | EP1047452B1 Conjugates comprising two active agents |
| 04/20/2005 | EP1009753B1 Hypoxia-regulated genes |
| 04/20/2005 | EP0954278B1 Pharmaceutical compositions containing kukui nut oil |
| 04/20/2005 | EP0949919B1 A process for stabilizing levogyre ascorbic acid (laa) and stable laa compositions |
| 04/20/2005 | EP0942752B1 Anticonvulsant containing composition for treating neuropathic pain |
| 04/20/2005 | EP0917471B1 Treatment and diagnosis of infections of gram positive cocci |
| 04/20/2005 | EP0805859B1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses |
| 04/20/2005 | CN1608069A Selective androgen receptor modulators and methods for their identification, design and use |
| 04/20/2005 | CN1608067A Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 04/20/2005 | CN1608062A Salt forms of e-2-methoxy-n-(3-{4-[3 methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide and method of production |
| 04/20/2005 | CN1607957A Modulation of excitable tissue function by peripherally administered erythropoietin |
| 04/20/2005 | CN1607954A Pregnane steroids for use in the treatment of cns dysfunction |
| 04/20/2005 | CN1607953A Non-nucleosidic inhibitors of reverse transcriptase as antagonists of cell proliferation and inducers of cell differentiation |
| 04/20/2005 | CN1607952A Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor |
| 04/20/2005 | CN1607951A Quinoline derivatives as neuropeptide y antagonists |
| 04/20/2005 | CN1607247A Dendritic cell tumor vaccine and its preparation and use |
| 04/20/2005 | CN1607006A Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| 04/20/2005 | CN1197966C Modulators of TNF receptor associated factor (TRAF), their preparation and use |
| 04/20/2005 | CN1197577C Therapeutic use of 4-anilino quinazoline derivative in preparing drug for preventing breast cancer paroxysm |
| 04/20/2005 | CN1197565C Method for preventing or delaying catheter-based revascularization |
| 04/20/2005 | CN1197554C Solid lipid formulations |
| 04/20/2005 | CN1197552C Preparations for the application of anti-inflammatory agents |
| 04/20/2005 | CN1197551C Dispersion formulations containing lipase inhibitors |
| 04/20/2005 | CN1197541C Two chamber cartridge for atomizers |
| 04/19/2005 | US6881833 Component in the hedgehog signalling pathway |
| 04/19/2005 | US6881756 Method for treating skin disorders |
| 04/19/2005 | US6881750 Potassium taurate bicarbonate and ascorbate |
| 04/19/2005 | US6881748 Drug targeting |
| 04/19/2005 | US6881746 Hypoglycemic agents; antidiabetic agents |
| 04/19/2005 | US6881744 Carbinoxamine tannate |
| 04/19/2005 | US6881741 Such as 3-(4-Chloro-2,5-dimethyl-benzenesulfonylamino)-5-(4-chloro-phenyl)-thiophene-2-carboxylic acid; for treatment of hepatitis |
| 04/19/2005 | US6881739 Use of cortisol antagonists in the treatment of heart failure |
| 04/19/2005 | US6881734 Pharmaceutical composition for the treatment of CNS and other disorders |
| 04/19/2005 | US6881575 Using fluorescent activated cell sorting to separate and isolate cells comprising mutations in cell proliferation; anticarcinogenic agents; antiproliferative agents |
| 04/19/2005 | US6881552 Human protease associated proteins |
| 04/19/2005 | US6881548 Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy |